This topic is empty. Viewing 0 reply threads Author Posts February 26, 2021 at 10:15 am #20679 MS News Today ModeratorParticipant The study of temelimab has enrolled 42 people with relapsing MS whose disability progressed in the absence of relapses after treatment with rituximab. Click here to learn more. Are you following this study? What do you think of the findings so far? Author Posts Viewing 0 reply threads You must be logged in to reply to this topic. Log In Username: Password: Keep me signed in Log in with Facebook or Log In